Combined morphological and interphase fluorescence in situ hybridization study in multiple myeloma of Chinese patients

被引:9
|
作者
Ng, MHL [1 ]
Kan, A
Chung, YF
Wong, IHN
Lo, KW
Wickham, NWR
Lei, KIK
Lee, JCK
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Hematol Sect, Sha Tin, Peoples R China
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Sha Tin, Peoples R China
来源
AMERICAN JOURNAL OF PATHOLOGY | 1999年 / 154卷 / 01期
关键词
D O I
10.1016/S0002-9440(10)65245-5
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
To gain insight into the real incidence of the numeric chromosomal aberrations and the cell lineage involvement of the neoplastic process hi multiple myeloma (MM), we examined 18 Chinese MM patients by May-Grunwald-Giemsa (MGG) staining and fluorescence in situ hybridization using three DNA centromeric probes specific for chromosomes 3, 7, and 9, In this investigation, cytogenetic abnormalities were detected in plasma cells (PCs), myeloid cells (MCs), and lymphoid cells (LCs) in all of the MM patients studied. This is the first demonstration of the cytogenetic aberration involved in the myeloid series. Furthermore, the MCs and PCs of IG MM patients had the same aneuploidies in one or more of the chromosomes analyzed. These data suggest that the neoplastic transformation of MM may occur early in the hematopoietic development. Chromosomal aberrations involving mainly subclones and considerable cellular heterogeneity with gain of a variety of copy numbers of the same chromosome were demonstrated within PCs, which may possibly be the result of an underlying defect of PCs in the control of their number of chromosomes. Whereas PCs showed evidence suggestive of increased polyploidization, MCs and LCs, which exhibited similar chromosomal patterns as the former, rarely did Thus, the clonal evolution from LC to PC, if that happens in MM, is characterized by chromosomal instability favoring growth of tumor cells with polysomies and polyploidies.
引用
收藏
页码:15 / 22
页数:8
相关论文
共 50 条
  • [21] Conventional Cytogenetics and Interphase Fluorescence In Situ Hybridization Results in Multiple Myeloma: A Turkey Laboratory Analysis of 381 Cases
    Aydin, Cigdem
    Ulas, Turgay
    Hangul, Ceren
    Yucel, Orhan Kemal
    Iltar, Utku
    Salim, Ozan
    Ekinci, Deniz
    Karauzum, Sibel Berker
    [J]. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2020, 36 (02) : 284 - 291
  • [22] Conventional Cytogenetics and Interphase Fluorescence In Situ Hybridization Results in Multiple Myeloma: A Turkey Laboratory Analysis of 381 Cases
    Cigdem Aydin
    Turgay Ulas
    Ceren Hangul
    Orhan Kemal Yucel
    Utku Iltar
    Ozan Salim
    Deniz Ekinci
    Sibel Berker Karauzum
    [J]. Indian Journal of Hematology and Blood Transfusion, 2020, 36 : 284 - 291
  • [23] Cytogenetics of multiple myeloma:: interpretation of fluorescence in situ hybridization results
    Harrison, CJ
    Mazzullo, H
    Cheung, KL
    Gerrard, G
    Jalali, GR
    Mehta, A
    Osier, DG
    Orchard, KH
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (06) : 944 - 952
  • [24] Longitudinal genetically detectable minimal residual disease by interphase fluorescence in situ hybridization confers a poor prognosis in multiple myeloma
    Cui, Jian
    Yu, Tengteng
    Yan, Wenqiang
    Xu, Jingyu
    Liu, Jiahui
    Fan, Huishou
    Qiu, Lugui
    An, Gang
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S226 - S226
  • [25] Monitoring of minimal residual disease in multiple myeloma by trisomy 9 cell detection using interphase fluorescence in situ hybridization
    Dascalescu, CM
    Nicolini, FE
    Molina, L
    Garban, F
    Chauvet, M
    Sotto, JJ
    Leroux, D
    [J]. EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 626 - 626
  • [26] Multiple Myeloma, Detection of Four Unfavorable Genetic Pronostic Factor by Interphase Two-Color Fluorescence in Situ Hybridization Analyses: A Study of 33 Patients At Diagnosis or Relapse
    Sergio Barragan, Carlo
    Hansson, Silvia B.
    Cicchini, Silvina A.
    Hidalgo, Federico J.
    Ochoa, Claudia E.
    Nunez, Gabriela
    Gabriela Flores, Maria
    Salvador, Teresa
    Saba, Silvia
    [J]. BLOOD, 2012, 120 (21)
  • [27] Value of comparative genomic hybridization and fluorescence in situ hybridization for molecular diagnostics in multiple myeloma
    Liebisch, P
    Viardot, A
    Bassermann, N
    Wendl, C
    Roth, K
    Goldschmidt, H
    Einsele, H
    Straka, C
    Stilgenbauer, S
    Döhner, H
    Bentz, M
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (02) : 193 - 201
  • [28] Cytogenetic analysis and fluorescence in situ hybridization in a case of IgD multiple myeloma
    Weinländer, G
    Drach, J
    Raderer, M
    Okamoto, I
    Ackermann, J
    Stögermayer, B
    Fazeny, B
    Nowotny, H
    Marosi, C
    [J]. CANCER GENETICS AND CYTOGENETICS, 1998, 105 (02) : 172 - 176
  • [29] FLUORESCENCE IN SITU HYBRIDIZATION DETECTION OF CYTOGENETIC ABNORMALITIES AND PROGNOSIS IN MULTIPLE MYELOMA
    Zhou, Xu
    Zhao, Jin
    Li, Zheng
    Wang, Jin
    [J]. ARCHIVES OF BIOLOGICAL SCIENCES, 2015, 67 (02) : 437 - 443
  • [30] Cytogenetic and fluorescence in situ hybridization studies in 60 patients with multiple myeloma and plasma cell leukemia
    Lloveras, E
    Granada, I
    Zamora, L
    Espinet, B
    Florensa, L
    Besses, C
    Xandri, M
    Pérez-Vila, ME
    Millà, F
    Woessner, S
    Solé, F
    [J]. CANCER GENETICS AND CYTOGENETICS, 2004, 148 (01) : 71 - 76